These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5643297)

  • 41. [Dose-effect of chemotherapy in bronchial small-cell cancer].
    de Crevoisier R; le Cesne A; le Chevalier T
    Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M
    Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative studies of patients with lung cancer treated with cyclophosphamide].
    Aszity M; Sashegyi B; Fábián S; Pálfy R; Dévényi Z
    Orv Hetil; 1973 Mar; 114(12):683-5. PubMed ID: 4688976
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of inoperable cancer of the lung.
    Wolf J
    Proc Natl Cancer Conf; 1970; 6():867-72. PubMed ID: 5458153
    [No Abstract]   [Full Text] [Related]  

  • 46. [Administration of phytohemagglutinin with cytostatic therapy].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(12):587-92. PubMed ID: 5385163
    [No Abstract]   [Full Text] [Related]  

  • 47. [Our experiences in the preoperative treatment of lung cancer with cyclophosphamide].
    Sashegyi B; Aszitry M; Fabian A
    Bronches; 1971; 21(2):176-80. PubMed ID: 5126168
    [No Abstract]   [Full Text] [Related]  

  • 48. Arterial perfusion of the breast with cytotoxic drugs.
    Lentin M; Nambiar R; Brennan TG
    Br J Surg; 1967 Jun; 54(6):519-21. PubMed ID: 6026323
    [No Abstract]   [Full Text] [Related]  

  • 49. [First clinical experiences with ultrahigh single doses of cyclophosphamide].
    Schmitz G; Gross R
    Med Welt; 1967 Apr; 16():985-9. PubMed ID: 5585096
    [No Abstract]   [Full Text] [Related]  

  • 50. Prolonged low-dosage administration of hexamethylmelamine (NC 13875).
    Wilson WL; Bisel HF; Cole D; Rochlin D; Ramirez G; Madden R
    Cancer; 1970 Mar; 25(3):568-70. PubMed ID: 5461337
    [No Abstract]   [Full Text] [Related]  

  • 51. [Case of lung carcinoma treated with massive intravenous administration of Endoxan].
    Frontczak J
    Gruzlica; 1971 May; 39(5):431-2. PubMed ID: 5563839
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.
    Diehl R; Ferrara F; Müller C; Dreyer AY; McLeod DD; Fricke S; Boltze J
    Cell Mol Immunol; 2017 Feb; 14(2):146-179. PubMed ID: 27721455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacokinetics of cyclophosphamide.
    de Jonge ME; Huitema AD; Rodenhuis S; Beijnen JH
    Clin Pharmacokinet; 2005; 44(11):1135-64. PubMed ID: 16231966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An assessment of massive-dose chemotherapy of malignant disease.
    Bergsagel DE
    Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068
    [No Abstract]   [Full Text] [Related]  

  • 56. Burkitt's lymphoma in Ibadan: hematologic response to single, large, intravenous dose of cyclophosphamide. Case reports.
    Durodola JI
    J Natl Med Assoc; 1976 May; 68(3):185-7. PubMed ID: 933184
    [No Abstract]   [Full Text] [Related]  

  • 57. Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.
    Lohrmann HP; Schreml W; Fliedner TM; Heimpel H
    Blut; 1979 Jan; 38(1):9-16. PubMed ID: 758963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacokinetics of cyclophosphamide.
    Grochow LB; Colvin M
    Clin Pharmacokinet; 1979; 4(5):380-94. PubMed ID: 389529
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 60. Changes in peripheral blood composition following single and repeated courses of intermittent cancer chemotherapy.
    Wiktor-Jedrzejczak W; Siekierzynski M; Rychowiecka E; Bukowska B; Czarnecki C
    Med Interne; 1982; 20(4):289-94. PubMed ID: 6985497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.